<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Derkach K</submitter><funding>Russian Science Foundation</funding><pagination>e0213779</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6417728</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(3)</volume><pubmed_abstract>In diet-induced obesity, metformin (MF) has weight-lowering effect and improves glucose homeostasis and insulin sensitivity. However, there is no information on the efficiency of MF and the mechanisms of its action in melanocortin-type obesity. We studied the effect of the 10-day treatment with MF at the doses of 200, 400 and 600 mg/kg/day on the food intake and the metabolic and hormonal parameters in female C57Bl/6J (genotype Ay/a) agouti-mice with melanocortin-type obesity, and the influence of MF on the hypothalamic signaling in obese animals at the most effective metabolic dose (600 mg/kg/day). MF treatment led to a decrease in food intake, the body and fat weights, the plasma levels of glucose, insulin and leptin, all increased in agouti-mice, to an improvement of the lipid profile a</pubmed_abstract><journal>PloS one</journal><pubmed_title>The evidence of metabolic-improving effect of metformin in Ay/a mice with genetically-induced melanocortin obesity and the contribution of hypothalamic mechanisms to this effect.</pubmed_title><pmcid>PMC6417728</pmcid><funding_grant_id>16-15-10388</funding_grant_id><pubmed_authors>Derkach K</pubmed_authors><pubmed_authors>Romanova I</pubmed_authors><pubmed_authors>Bakhtyukov A</pubmed_authors><pubmed_authors>Zakharova I</pubmed_authors><pubmed_authors>Zorina I</pubmed_authors><pubmed_authors>Bayunova L</pubmed_authors><pubmed_authors>Shpakov A</pubmed_authors></additional><is_claimable>false</is_claimable><name>The evidence of metabolic-improving effect of metformin in Ay/a mice with genetically-induced melanocortin obesity and the contribution of hypothalamic mechanisms to this effect.</name><description>In diet-induced obesity, metformin (MF) has weight-lowering effect and improves glucose homeostasis and insulin sensitivity. However, there is no information on the efficiency of MF and the mechanisms of its action in melanocortin-type obesity. We studied the effect of the 10-day treatment with MF at the doses of 200, 400 and 600 mg/kg/day on the food intake and the metabolic and hormonal parameters in female C57Bl/6J (genotype Ay/a) agouti-mice with melanocortin-type obesity, and the influence of MF on the hypothalamic signaling in obese animals at the most effective metabolic dose (600 mg/kg/day). MF treatment led to a decrease in food intake, the body and fat weights, the plasma levels of glucose, insulin and leptin, all increased in agouti-mice, to an improvement of the lipid profile a</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019</publication><modification>2026-05-07T10:09:08.43Z</modification><creation>2026-04-07T22:46:56.262Z</creation></dates><accession>S-EPMC6417728</accession><cross_references><pubmed>30870482</pubmed><doi>10.1371/journal.pone.0213779</doi></cross_references></HashMap>